Feb 12 2026
Legislation in Virginia that would require medical care facilities to allow certain terminally ill patients to use medical marijuana during inpatient stays has advanced in the House with a substitute approved by the House Committee on Health and Human Services.
Feb 12 2026
Tilray Brands announced today that its European pharmaceutical arm, CC Pharma, has entered into a new agreement with UK-based Smartway Pharmaceuticals designed to expand access to medicines across Britain through pharmacy, hospital and specialist care channels.
Feb 11 2026
Legislation that would establish a regulated adult-use marijuana market in Virginia was approved today by the House Appropriations Committee in a 16 to 6 vote, sending the measure to the full House of Delegates for consideration.
Feb 11 2026
New York lawmakers have given final approval to legislation that would loosen where adult-use marijuana dispensaries are allowed to operate by allowing them to open near places of worship, sending the measure to the governor for consideration.
Feb 11 2026
Florida’s Fifth District Court of Appeals has affirmed the state’s authority to enforce limits on total THC concentration in hemp products, siding with the Florida Department of Agriculture and Consumer Services in a case that could have significantly altered how intoxicating hemp products are regulated.
Feb 11 2026
A federal bill designed to block marijuana businesses from claiming standard tax deductions even if marijuana is rescheduled has gained its 15th sponsor in the House and Senate, and its second new sponsor this week.
Feb 11 2026
A New York Senate committee has advanced legislation that would allow individuals on parole, probation, or other forms of state supervision to work in the legal cannabis industry.
Feb 11 2026
A bipartisan group of Wyoming lawmakers introduced legislation today that would reschedule cannabis under state law, moving it to Schedule III. This follows similar proposals being filed in Kansas, Mississippi, and West Virginia.
Feb 11 2026
A new peer-reviewed study published in Drug Delivery and Translational Research by researchers from Florida A&M University reports that combining the non-intoxicating cannabinoids cannabichromene (CBC) and cannabidiol (CBD) produced strong anti-tumor effects against a form of triple-negative breast cancer (TNBC) that had become resistant to the chemotherapy drug doxorubicin.
Feb 10 2026
A New York Assembly proposal that would loosen where adult-use marijuana dispensaries are allowed to operate advanced Tuesday after being approved by two key committees in a single day, positioning the measure for potential floor action in the near future.
